Therefore, we hypothesize that berberine inhibits intestinal tumor development in Apcmin/+ mice through concomitant suppression of EGFR pathway, leading to decreasing tumor cell proliferation and increasing apoptosis. This evidence concerns the gene EGFR and neoplasm.